Jean-Marie Eveillard - First Eagle U.S. Value Portfolio
| Period Date | Jun 30, 2025 | |
| Filing Date | Aug 06, 2025 | |
| Total Stocks | 391 | |
| Portfolio Value | $49.97B |
First Eagle U.S. Value Options Activity
| Date | Symbol | Option | Quantity |
|---|---|---|---|
| Q1 2017 | BIIB Biogen Inc. | CALL | 1,000 |
| Q1 2017 | GILD Gilead Sciences, Inc. | CALL | 300 |
| Q4 2016 | GILD Gilead Sciences, Inc. | CALL | 300 |
| Q4 2016 | SRPT Sarepta Therapeutics, Inc. | CALL | 300 |
| Q3 2016 | GILD Gilead Sciences, Inc. | CALL | 300 |
| Q3 2016 | SRPT Sarepta Therapeutics, Inc. | CALL | 300 |
| Q4 2015 | HPE Hewlett Packard Enterprise Comp | CALL | 2,000 |
| Q4 2015 | SGMO Sangamo Therapeutics, Inc. | CALL | 3,259 |
| Q3 2015 | SGMO Sangamo Therapeutics, Inc. | CALL | 6,517 |
| Q3 2015 | SPY SPDR S&P 500 | CALL | 2,275 |
| Q2 2015 | SGMO Sangamo Therapeutics, Inc. | CALL | 4,017 |
| Q1 2015 | SGMO Sangamo Therapeutics, Inc. | CALL | 4,017 |
| Q4 2014 | EWH iShares MSCI Hong Kong Index Fu | PUT | 1,000 |
| Q4 2014 | GILD Gilead Sciences, Inc. | CALL | 1,200 |
| Q4 2014 | SGMO Sangamo Therapeutics, Inc. | CALL | 4,017 |
| Q3 2014 | EWH iShares MSCI Hong Kong Index Fu | PUT | 1,000 |
| Q3 2014 | SGMO Sangamo Therapeutics, Inc. | CALL | 4,000 |
| Q2 2014 | SGMO Sangamo Therapeutics, Inc. | CALL | 2,500 |
| Q1 2014 | GERN Geron Corporation | CALL | 2,013 |
| Q1 2014 | SUP Superior Industries Internation | CALL | 520 |
| Q4 2013 | GERN Geron Corporation | CALL | 6,511 |
| Q4 2013 | MS Morgan Stanley | PUT | 1,700 |
| Q4 2013 | SEE Sealed Air Corporation | CALL | 1,000 |